{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:25:00Z","timestamp":1758057900612,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejphar.2020.173316","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T02:43:36Z","timestamp":1593571416000},"page":"173316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model"],"prefix":"10.1016","volume":"882","author":[{"given":"Fran\u00e7ois","family":"Briand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Brousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Maupoint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Dubroca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Costard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Breyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"Burcelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7 Suppl. l","key":"10.1016\/j.ejphar.2020.173316_bib1","first-page":"s176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejphar.2020.173316_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173316_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0361-9230(03)00188-6","article-title":"High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors","volume":"61","author":"Barnes","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2020.173316_bib4","first-page":"349","article-title":"Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat","volume":"58","author":"Bojanowska","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173316_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3945\/jn.111.153197","article-title":"High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters","volume":"142","author":"Briand","year":"2012","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2020.173316_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejphar.2017.11.021","article-title":"Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the diet-induced NASH (DIN) hamster model","volume":"818","author":"Briand","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173316_bib7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/db09-1564","article-title":"Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats","volume":"59","author":"Cummings","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173316_bib8","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173316_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/aps.2011.168","article-title":"Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats","volume":"33","author":"Hansen","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2020.173316_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.84","article-title":"Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity","volume":"3","author":"Higgins","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejphar.2020.173316_bib12","doi-asserted-by":"crossref","first-page":"107417","DOI":"10.1016\/j.pharmthera.2019.107417","article-title":"Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential","volume":"205","author":"Higgins","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173316_bib13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3892\/mmr.2014.1956","article-title":"Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of the IRE-\u03b1 pathway","volume":"9","author":"Ji","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2020.173316_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3803\/EnM.2015.30.4.557","article-title":"Diastolic dysfunction induced by a high-fat diet is associated with mitochondrial abnormality and adenosine triphosphate levels in rats","volume":"30","author":"Kang","year":"2015","journal-title":"Endocrinol. Metab. (Seoul)."},{"key":"10.1016\/j.ejphar.2020.173316_bib15","doi-asserted-by":"crossref","first-page":"8543763","DOI":"10.1155\/2018\/8543763","article-title":"Molecular pathogenesis of nonalcoholic steatohepatitis- (NASH-) related hepatocellular carcinoma","volume":"2018","author":"Kutlu","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173316_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ijo.2013.159","article-title":"The snacking rat as model of human obesity: effects of a free-choice high-fat high-sugar diet on meal patterns","volume":"38","author":"La Fleur","year":"2014","journal-title":"Int. J. Obes. (Lond)."},{"key":"10.1016\/j.ejphar.2020.173316_bib17","first-page":"423","article-title":"Cardiac remodeling in a rat model of diet-induced obesity","volume":"26","author":"Leopoldo","year":"2010","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173316_bib18","doi-asserted-by":"crossref","first-page":"630537","DOI":"10.1155\/2013\/630537","article-title":"Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway","volume":"2013","author":"Liu","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2020.173316_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/oby.2003.30","article-title":"DNA microarray analysis of genes differentially expressed in \u00f3diet-induced (cafeteria) obese rats","volume":"11","author":"L\u00f3pez","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.ejphar.2020.173316_bib20","doi-asserted-by":"crossref","first-page":"317\u2010332","DOI":"10.1111\/dom.12596","article-title":"Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists","volume":"18","author":"Madsbad","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2020.173316_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.ejphar.2020.173316_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2007.11.077","article-title":"Putting the diet back into diet-induced obesity: diet-induced hypothalamic gene expression","volume":"585","author":"Mercer","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"11, Suppl. 1","key":"10.1016\/j.ejphar.2020.173316_bib23","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2020.173316_bib24","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1080\/07315724.2010.10719844","article-title":"Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils","volume":"29","author":"Misra","year":"2010","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ejphar.2020.173316_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2016.10.015","article-title":"Obesity: current and potential pharmacotherapeutics and targets","volume":"170","author":"Narayanaswami","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173316_bib26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1590\/S0004-27302008000600007","article-title":"A hypercaloric pellet-diet cycle induces obesity and co-morbidities in Wistar rats","volume":"52","author":"Nascimento","year":"2008","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.173316_bib27","doi-asserted-by":"crossref","first-page":"H2401","DOI":"10.1152\/ajpheart.00347.2005","article-title":"Active metabolite of GLP-1 mediates myocardial glucose uptake and improve left ventricular performance in conscious dog with dilated cardiomyopathy","volume":"289","author":"Nikolaidis","year":"2005","journal-title":"Am. J. Physio. Heart. Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173316_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173316_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0028-1082326","article-title":"The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance","volume":"40","author":"Nystr\u00f6m","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2020.173316_bib30","first-page":"407","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the Lira-NAFLD study","volume":"102","author":"Petit","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2020.173316_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.metabol.2018.10.010","article-title":"Pharmacotherapy of obesity: available medications and drugs under investigation","volume":"92","author":"Pilitsi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2020.173316_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173316_bib33","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s12325-016-0414-6","article-title":"Reward-induced eating: therapeutic approaches to addressing food cravings","volume":"33","author":"Rebello","year":"2016","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2020.173316_bib34","first-page":"383","article-title":"Diet-induced obesity: rodent model for the study of obesity-related disorders","volume":"58","author":"Rosini","year":"2012","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ejphar.2020.173316_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/1570161114666160722121615","article-title":"Interrelationships with metabolic syndrome, obesity and cardiovascular risk","volume":"14","author":"Said","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173316_bib36","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.2337\/db16-1206","article-title":"Glucagon-like peptide 1 receptor activation augments cardiac output and improves cardiac efficiency in obese swine after myocardial infarction","volume":"66","author":"Sassoon","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173316_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bph.12943","article-title":"Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes","volume":"173","author":"Tate","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173316_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00019.2009","article-title":"Metabolic effects of fructose and the worldwide increase in obesity","volume":"90","author":"Tappy","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2020.173316_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/nu11091987","article-title":"Dietary fructose and the metabolic syndrome","volume":"11","author":"Taskinen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2020.173316_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12576-016-0504-x","article-title":"Canola oil rich in oleic acid improves diastolic heart function in diet-induced obese rats","volume":"67","author":"Thandapilly","year":"2017","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.ejphar.2020.173316_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization","volume":"325","author":"Thomsen","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.173316_bib42","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1038\/s41598-018-28314-z","article-title":"Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome","volume":"8","author":"Toots","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173316_bib43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/dom.13655","article-title":"Lorcaserin treatment decreases body weight and reduced cardiometabolic risk factors in obese adults: a six-month, randomized, placebo-controlled, double-blind clinical trial","volume":"21","author":"Tuccinardi","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2020.173316_bib44","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/ATVBAHA.118.310990","article-title":"Liraglutide reduces postprandial hyperlipidemia by increasing ApoB48 (apolipoprotein B48) catabolism and by reducing ApoB48 production in patients with type 2 diabetes mellitus","volume":"38","author":"Verg\u00e8s","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2020.173316_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ejphar.2020.173316_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCIMAGING.112.000128","article-title":"Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials","volume":"6","author":"Weissman","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2020.173316_bib47","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","article-title":"The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes","volume":"53","author":"Winzell","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2020.173316_bib48","article-title":"Liraglutide protects cardiac function in diabetic rats through the PPAR\u03b1 pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2020.173316_bib49","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide -1 on myocardium contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920304088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920304088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:41:23Z","timestamp":1757976083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920304088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"alternative-id":["S0014299920304088"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173316","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173316"}}